ICCC Earnings

Quarterly EPS
$-0.09
Q3 2024
$0.06
Q4 2024
$0.16
Q1 2025
$0.06
Q2 2025
$-0.02
Q3 2025
$-0.31
Q4 2025
$0.21
Q1 2026
$0.20
Q2 2026
Latest Revenue7.2M
Latest Net Income1.8M
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026$0.207.2M1.8M+11.5%+233.3%
Q1 2026$0.2110.4M1.9M+28.4%+31.2%
Q4 2025-$0.317.6M-2849142-1.6%-616.7%
Q3 2025-$0.025.5M-139748-8.4%+77.8%
Q2 2025$0.066.4M501.9K+17.8%+130.0%
Q1 2025$0.168.1M1.4M+11.2%+366.7%
Q4 2024$0.067.8M514.6K+52.1%+140.0%
Q3 2024-$0.096.0M-701690+11.4%+25.0%
Q2 2024-$0.205.5M-1531626
Q1 2024-$0.067.3M-437868
Q4 2023-$0.155.1M-1139831
Q3 2023-$0.125.4M-940000
Immucell (ICCC) — Earnings